BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23552869)

  • 1. Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.
    Sun PH; Ye L; Mason MD; Jiang WG
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1129-39. PubMed ID: 23552869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.
    Sun PH; Ye L; Mason MD; Jiang WG
    PLoS One; 2012; 7(11):e50183. PubMed ID: 23185569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway.
    Sun PH; Ye L; Mason MD; Jiang WG
    Int J Oncol; 2013 Nov; 43(5):1560-8. PubMed ID: 24002526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.
    Sun PH; Chen G; Mason M; Jiang WG; Ye L
    Int J Oncol; 2017 Apr; 50(4):1127-1135. PubMed ID: 28259897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
    Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
    Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PTPRK Promotes Cell Proliferation and Metastasis of NSCLC by Enhancing STAT3 Activation.
    Xu X; Li D; Liu J; Ma Z; Huang H; Min L; Dai L; Dong S
    Anal Cell Pathol (Amst); 2019; 2019():4265040. PubMed ID: 30838170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma.
    Agarwal S; Al-Keilani MS; Alqudah MA; Sibenaller ZA; Ryken TC; Assem M
    PLoS One; 2013; 8(5):e62852. PubMed ID: 23696788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
    Philippin-Lauridant G; Baranzelli MC; Samson C; Fournier C; Pinte S; Mattot V; Bonneterre J; Soncin F
    Int J Oncol; 2013 Apr; 42(4):1367-75. PubMed ID: 23404186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.
    Chung YR; Kim H; Park SY; Park IA; Jang JJ; Choe JY; Jung YY; Im SA; Moon HG; Lee KH; Suh KJ; Kim TY; Noh DY; Han W; Ryu HS
    Hum Pathol; 2015 Jul; 46(7):1027-35. PubMed ID: 26004371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.
    Freitas VM; do Amaral JB; Silva TA; Santos ES; Mangone FR; Pinheiro Jde J; Jaeger RG; Nagai MA; Machado-Santelli GM
    Mol Cancer; 2013 Jan; 12():2. PubMed ID: 23289900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.
    Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG
    Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes.
    Xu Y; Xue S; Zhou J; Voorhees JJ; Fisher GJ
    Mol Biol Cell; 2015 Mar; 26(6):1199-206. PubMed ID: 25609089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
    Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
    Wang S; Li H; Wang J; Wang D; Yao A; Li Q
    Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
    Yin Y; Sanders AJ; Jiang WG
    Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
    Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
    BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133.
    Matsushita M; Mori Y; Uchiumi K; Ogata T; Nakamura M; Yoda H; Soda H; Takiguchi N; Nabeya Y; Shimozato O; Ozaki T
    FEBS Open Bio; 2019 May; 9(5):935-946. PubMed ID: 30947381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma.
    Wachtel MS; Halldorsson A; Dissanaike S
    J Surg Res; 2011 Mar; 166(1):19-27. PubMed ID: 20828724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells.
    Novellino L; De Filippo A; Deho P; Perrone F; Pilotti S; Parmiani G; Castelli C
    Cell Signal; 2008 May; 20(5):872-83. PubMed ID: 18276111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.